GSA Capital Partners’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-4,808
Closed -$555K 1755
2022
Q4
$555K Buy
4,808
+2,603
+118% +$300K 0.07% 537
2022
Q3
$239K Buy
+2,205
New +$239K 0.03% 1083
2022
Q2
Sell
-1,586
Closed -$271K 1640
2022
Q1
$271K Buy
+1,586
New +$271K 0.04% 972
2021
Q3
Sell
-2,471
Closed -$699K 1641
2021
Q2
$699K Buy
2,471
+192
+8% +$54.3K 0.08% 426
2021
Q1
$483K Sell
2,279
-10,439
-82% -$2.21M 0.08% 372
2020
Q4
$2.5M Buy
+12,718
New +$2.5M 0.41% 9
2020
Q3
Sell
-1,631
Closed -$226K 1331
2020
Q2
$226K Buy
+1,631
New +$226K 0.13% 286
2019
Q3
Sell
-6,045
Closed -$776K 1579
2019
Q2
$776K Sell
6,045
-856
-12% -$110K 0.09% 379
2019
Q1
$880K Sell
6,901
-8,093
-54% -$1.03M 0.09% 358
2018
Q4
$1.88M Buy
14,994
+7,084
+90% +$886K 0.22% 60
2018
Q3
$1.75M Sell
7,910
-12,718
-62% -$2.82M 0.1% 310
2018
Q2
$3.3M Buy
20,628
+14,869
+258% +$2.38M 0.16% 91
2018
Q1
$538K Sell
5,759
-12,355
-68% -$1.15M 0.03% 1023
2017
Q4
$1.27M Sell
18,114
-21,335
-54% -$1.49M 0.08% 453
2017
Q3
$2.34M Sell
39,449
-1,726
-4% -$102K 0.16% 108
2017
Q2
$1.71M Sell
41,175
-72,063
-64% -$2.99M 0.11% 218
2017
Q1
$5.02M Buy
113,238
+16,334
+17% +$725K 0.27% 14
2016
Q4
$4.03M Sell
96,904
-11,783
-11% -$491K 0.24% 33
2016
Q3
$4.11M Sell
108,687
-6,301
-5% -$238K 0.22% 37
2016
Q2
$3.83M Buy
114,988
+9,042
+9% +$301K 0.21% 42
2016
Q1
$3.2M Buy
105,946
+8,347
+9% +$252K 0.2% 57
2015
Q4
$2.97M Buy
97,599
+45,821
+88% +$1.39M 0.15% 127
2015
Q3
$1.39M Sell
51,778
-13,584
-21% -$365K 0.07% 436
2015
Q2
$2.11M Sell
65,362
-11,194
-15% -$362K 0.08% 334
2015
Q1
$2.29M Buy
76,556
+18,097
+31% +$542K 0.09% 268
2014
Q4
$1.96M Buy
58,459
+11,879
+26% +$398K 0.14% 157
2014
Q3
$1.53M Buy
46,580
+10,600
+29% +$348K 0.08% 288
2014
Q2
$1.09M Buy
35,980
+20,682
+135% +$629K 0.05% 625
2014
Q1
$445K Sell
15,298
-3,200
-17% -$93.1K 0.03% 865
2013
Q4
$483K Sell
18,498
-10,540
-36% -$275K 0.04% 868
2013
Q3
$781K Sell
29,038
-4,800
-14% -$129K 0.06% 494
2013
Q2
$872K Buy
+33,838
New +$872K 0.1% 263